Price movement over the last 24 hours
ARK Genomic Revolution ETF vs Global Payments Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.21, while Global Payments Inc trades at $76.09 (market cap $20.80B). The key difference: Global Payments Inc pays a 1.32% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Global Payments Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | GPN | |
|---|---|---|
Sector | Sector/Thematic | Industrials |
52-Week High | $43.57 | $90.01 |
52-Week Low | $23.09 | $62.47 |
Market Cap | — | $20.80B |
Enterprise Value | — | $38.52B |
Dividend Yield | — | 1.32% |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Global Payments (GPN) trades at $76.04, up 2.23% on the day, with a bullish technical signal from moving averages and strong earnings beats in recent quarters. The company maintains solid operating cash flow of $2.66B for 2025 and a gross profit margin of 67.34%, though net income margin turned negative at -7.97% for 2026. Recent developments include AI-powered POS launches and expansion of restaurant partnerships, driving positive analyst sentiment with a consensus price target of $81.56.
GPN presents a mixed outlook: upside exists from earnings momentum and strategic initiatives like the Worldpay integration, but risks include margin pressure, rising debt-to-asset ratio of 41.57%, and intense fintech competition. The stock's current valuation at a P/E of 27.96 appears reasonable relative to growth prospects, yet investors must weigh execution risks against potential rewards in a competitive payments landscape.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Global Payments is a leading provider of payment processing and software solutions and focuses on serving small and midsize merchants. The company operates in 30 countries and generates about one fourth of its revenue from outside North America, primarily in Europe and Asia. In 2019, Global Payments merged with Total System Services in an all-stock deal that gave Total System Services shareholders 48% of the combined company's shares.
Read more on GPN →